SARAH WHITTLE

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address6701 FANNIN
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Baday YI, Navai SA, Hicks MJ, Venkatramani R, Whittle SB. Pediatric liposarcoma: A case series and literature review. Pediatr Blood Cancer. 2021 Sep 14; e29327. PMID: 34520106.
      Citations:    Fields:    
    2. Whittle SB, Offer K, Roberts RD, LeBlanc A, London C, Majzner RG, Huang AY, Houghton P, Alejandro Sweet Cordero E, Grohar PJ, Isakoff M, Bishop MW, Stewart E, Slotkin EK, Greengard E, Borinstein SC, Navid F, Gorlick R, Janeway KA, Reed DR, Hingorani P. Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force. Pediatr Blood Cancer. 2021 Sep; 68(9):e29188. PMID: 34137164.
      Citations:    Fields:    
    3. Hillier K, Cheng WS, Whittle SB, Krance R, Foster JH. Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant. J Pediatr Hematol Oncol. 2020 10; 42(7):e569-e574. PMID: 32032244.
      Citations: 1     Fields:    Translation:Humans
    4. Smith VR, Whittle SB, Coleman RD, Munoz FM, De Guzman MM, Foster JH, Navai SA. Severe COVID-19 infection in a child receiving immunotherapy for cancer. Pediatr Blood Cancer. 2021 03; 68(3):e28710. PMID: 32930438.
      Citations: 2     Fields:    Translation:Humans
    5. Whittle SB, Smith V, Silverstein A, Parmeter M, Minard CG, Bernhardt MB, Zage PE, Venkatramani R, Nuchtern JG, Heczey A, Russell HV, Shohet JM, Foster JH. Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417. PMID: 32729196.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    6. Silverstein A, Reddy K, Smith V, Foster JH, Russell HV, Whittle SB. Blood product administration during high risk neuroblastoma therapy. Pediatr Hematol Oncol. 2020 Feb; 37(1):5-14. PMID: 31829069.
      Citations:    Fields:    Translation:Humans
    7. Whittle SB, Hicks MJ, Roy A, Vasudevan SA, Reddy K, Venkatramani R. Congenital spindle cell rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27935. PMID: 31339226.
      Citations: 2     Fields:    Translation:Humans
    8. Whittle SB, Lopez MA, Russell HV. Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations. Pediatr Blood Cancer. 2019 07; 66(7):e27739. PMID: 30989762.
      Citations: 2     Fields:    Translation:Humans
    9. Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric Solid Tumors in Children and Adolescents: An Overview. Pediatr Rev. 2018 Sep; 39(9):444-453. PMID: 30171055.
      Citations: 5     Fields:    Translation:Humans
    10. Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric Solid Tumors of Infancy: An Overview. Pediatr Rev. 2018 Feb; 39(2):57-67. PMID: 29437125.
      Citations: 11     Fields:    Translation:Humans
    11. Lindsay H, Bhar S, Bonifant C, Sartain S, Whittle SB, Lee-Kim Y, Shah MD. Work efficiency improvement of >90% after implementation of an annual inpatient blood products administration consent form. BMJ Open Qual. 2018; 7(1):e000164. PMID: 29333497.
      Citations:    
    12. Whittle SB, Williamson KC, Russell HV. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma. Pediatr Hematol Oncol. 2017 Aug; 34(5):331-342. PMID: 29200325.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    13. Whittle SB, Punia JN, López-Terrada D, Gaikwad A, Hampton OA, Heczey A. Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma. J Pediatr Hematol Oncol. 2017 11; 39(8):e486-e488. PMID: 28902076.
      Citations:    Fields:    Translation:HumansCells
    14. Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017 Apr; 17(4):369-386. PMID: 28142287.
      Citations: 71     Fields:    Translation:Humans
    15. Whittle SB, Patel K, Zhang L, Woodfield SE, Du M, Smith V, Zage PE. The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma. Invest New Drugs. 2016 12; 34(6):685-692. PMID: 27586230.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    16. Zage PE, Whittle SB, Shohet JM. CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family. J Cell Biochem. 2017 02; 118(2):221-231. PMID: 27428599.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    17. Whittle SB, Reyes S, Du M, Gireud M, Zhang L, Woodfield SE, Ittmann M, Scheurer ME, Bean AJ, Zage PE. A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation. J Pediatr Hematol Oncol. 2016 Mar; 38(2):131-8. PMID: 26840079.
      Citations: 4     Fields:    Translation:Humans
    18. Woodfield SE, Guo RJ, Liu Y, Major AM, Hollingsworth EF, Indiviglio S, Whittle SB, Mo Q, Bean AJ, Ittmann M, Lopez-Terrada D, Zage PE. Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B. Genes Cancer. 2016 Jan; 7(1-2):13-26. PMID: 27014418.
      Citations: 5     
    19. Drolet BC, Whittle SB, Khokhar MT, Fischer SA, Pallant A. Approval and perceived impact of duty hour regulations: survey of pediatric program directors. Pediatrics. 2013 Nov; 132(5):819-24. PMID: 24101756.
      Citations: 10     Fields:    Translation:Humans
    20. Whittle S, Gosain A, Brown PY, Debelenko L, Raimondi S, Wilimas JA, Jenkins JJ, Davidoff AM. Regression of a congenital mesoblastic nephroma. Pediatr Blood Cancer. 2010 Aug; 55(2):364-8. PMID: 20582939.
      Citations: 3     Fields:    Translation:Humans
    21. McCarville MB, Whittle SB, Goodin GS, Li CS, Smeltzer MP, Hale GA, Kaufman RA. Clinical and CT features of benign pneumatosis intestinalis in pediatric hematopoietic stem cell transplant and oncology patients. Pediatr Radiol. 2008 Oct; 38(10):1074-83. PMID: 18665358.
      Citations: 9     Fields:    Translation:Humans
    WHITTLE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (128)
    Explore
    _
    Co-Authors (30)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _